Stefanie Schulz in conversation with Ulf Landmesser ISAR REACT 3A: A trial of reduced dose of unfractionated...

Sunil Rao in conversation with Thomas Lüscher INNOVATE PCI: A Phase II Safety and Efficacy Study of PRT060128...

Stuart Connolly in conversation with Thomas Lüscher AVERROES: Apixaban Versus Acetylsalicyclic Acid (ASA) to...

Adriaan Voors in a conversation with Thomas Lüscher HEBE III: A single dose of erhthropoietin in ST-elevation...

Bertram Pitt in conversation with Frank Ruschitzka PEARL HF: Multicentre, randomized, double-blind,...

Daan Kromhout in conversation with John Deanfield ALPHA OMEGA: Effect of low doses of n-3 fatty acids on...

Shinya Goto in conversation with Ulf Landmesser Double-blind placebo controlled phase II studies of E5555 in...

Michael Komajda in conversation with Frank Ruschitzka SHIFT: Effects of ivabradine on cardiovascular events in...

David Taggart in conversation with Ulf Landmesser ART: A randomised trial to compare survival following bilateral...